GGrantIndex
← Leaderboards

Walter J Curran

Thomas Jefferson University

$890,256
Attributed
$890,256
Total exposure
3
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$46,226,987 · 6

By mechanism

U10$40,750,065 · 4
P01$5,476,922 · 2

Top collaborators

No co-investigators on record.

Most similar at Thomas Jefferson University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman Therapy EvaluationHuman SubjectNeoplasm /Cancer Radiation TherapyNeoplasm /Cancer SurgeryColorectal NeoplasmsCombination Cancer TherapyAntineoplasticsNeoplasm /Cancer ChemotherapyClinical TrialsCombination ChemotherapyCooperative StudyReproductive System NeoplasmHead /Neck NeoplasmBrain NeoplasmsNeoplasm /Cancer GeneticsUrinary Tract NeoplasmsNeoplasm /CancerLung NeoplasmsGastrointestinal NeoplasmsAdenocarcinomaCamptothecinClinical Trial Phase IFluorouracil

Grant awards (25)

RADIATION THERAPY ONCOLOGY GROUP$8,232,670
U10 · FY2003 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,160,271
P01 · FY2003 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$914,646
U10 · FY2003 · CA
RADIATION THERAPY ONCOLOGY GROUP$749,739
U10 · FY2003 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$17,422
P01 · FY2003 · CA
RTOG Foreign Accrual$0
U10 · FY2003 · CA
Foreign Accrual - RTOG$0
U10 · FY2003 · CA
RADIATION THERAPY ONCOLOGY GROUP$9,394,973
U10 · FY2002 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,129,628
P01 · FY2002 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$565,667
U10 · FY2002 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$296,752
P01 · FY2002 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$296,752
P01 · FY2002 · CA
RADIATION THERAPY ONCOLOGY GROUP$200,000
U10 · FY2002 · CA
RADIATION THERAPY ONCOLOGY GROUP$135,118
U10 · FY2002 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$47,100
P01 · FY2002 · CA
RADIATION THERAPY ONCOLOGY GROUP$8,726,169
U10 · FY2001 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$1,418,941
U10 · FY2001 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,094,222
P01 · FY2001 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$296,752
P01 · FY2001 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$47,100
P01 · FY2001 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$0
P01 · FY2001 · CA
RADIATION THERAPY ONCOLOGY GROUP$9,191,105
U10 · FY2000 · CA
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE$1,221,037
U10 · FY2000 · CA
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER$1,090,923
P01 · FY2000 · CA
INNOVATIVE APPROACHES TO PATIENTS WITH ADENOCARCINOMA$0
P01 · FY2000 · CA